SA
Saudi Arabia
Navigate SFDA regulatory pathways and NUPCO tender opportunities, with attention to oncology and rare-disease portfolios.
MENA REGION
Opportunity across the GCC & MENA region.
We connect global life-science innovation with commercial opportunities in Saudi Arabia, the UAE, Qatar, Oman, Bahrain and Kuwait.
ACROSS BORDERS
From Canada and the USA to the Gulf.
Additional source markets: United Kingdom · Europe · Australia
OUR COUNTRY FOCUS
Understand the market. Find your route.
AE
United Arab Emirates
Consider Emirates Drug Establishment product regulation, relevant DHA healthcare channels and private-sector opportunities for advanced technologies.
QA
Qatar
Explore HMC and PHCC channels, specialized-care needs and public procurement considerations. Product pathways sit with the Ministry of Public Health.
OM
Oman
Assess Ministry of Health procurement, private-healthcare channels and opportunities for medical devices.
BH
Bahrain
Understand NHRA requirements, tender opportunities and pathways relevant to rare-disease portfolios.
KW
Kuwait
Plan around Ministry of Health procurement and tender processes for oncology and specialty products.
COMMERCIAL CONTEXT
Plan for the healthcare system behind the opportunity.
Assess specialized-care needs, public investment priorities and the channels through which products are evaluated and purchased.
Specialized care
Consider oncology and rare-disease needs, advanced therapies, medical devices and diagnostics.
Procurement and access
Understand government tenders, pricing, reimbursement and local partner requirements.
Public and private channels
Evaluate public healthcare priorities, private-sector routes and country-specific technology adoption.
YOUR NEXT MARKET
Let’s build your commercial presence.
Bring your portfolio, questions and ambitions. Let’s explore the right next step.
Discuss your portfolio